14-88824709-T-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_144596.4(TTC8):āc.2T>Cā(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000619 in 1,454,278 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 0.0000062 ( 0 hom. )
Consequence
TTC8
NM_144596.4 start_lost
NM_144596.4 start_lost
Scores
3
7
6
Clinical Significance
Conservation
PhyloP100: 2.97
Genes affected
TTC8 (HGNC:20087): (tetratricopeptide repeat domain 8) This gene encodes a protein that has been directly linked to Bardet-Biedl syndrome. The primary features of this syndrome include retinal dystrophy, obesity, polydactyly, renal abnormalities and learning disabilities. Experimentation in non-human eukaryotes suggests that this gene is expressed in ciliated cells and that it is involved in the formation of cilia. A mutation in this gene has also been implicated in nonsyndromic retinitis pigmentosa. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTC8 | NM_144596.4 | c.2T>C | p.Met1? | start_lost | 1/15 | ENST00000380656.7 | NP_653197.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTC8 | ENST00000380656.7 | c.2T>C | p.Met1? | start_lost | 1/15 | 2 | NM_144596.4 | ENSP00000370031.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000858 AC: 2AN: 232976Hom.: 0 AF XY: 0.00000785 AC XY: 1AN XY: 127434
GnomAD3 exomes
AF:
AC:
2
AN:
232976
Hom.:
AF XY:
AC XY:
1
AN XY:
127434
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000619 AC: 9AN: 1454278Hom.: 0 Cov.: 31 AF XY: 0.00000553 AC XY: 4AN XY: 722790
GnomAD4 exome
AF:
AC:
9
AN:
1454278
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
722790
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Bardet-Biedl syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 26, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals with TTC8-related conditions. This variant is present in population databases (rs776086794, ExAC 0.03%). This sequence change affects the initiator methionine of the TTC8 mRNA. The next in-frame methionine is located at codon 5. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.;.;T;T;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D;D;.;.;D;.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
PROVEAN
Uncertain
D;.;N;.;N;N;N;N;N
REVEL
Uncertain
Sift
Uncertain
D;.;D;.;D;D;D;D;D
Sift4G
Uncertain
D;D;D;D;D;D;T;D;D
Polyphen
0.37, 0.13, 0.0070
.;.;B;.;.;.;B;B;B
Vest4
MutPred
Gain of phosphorylation at M1 (P = 0.0395);Gain of phosphorylation at M1 (P = 0.0395);Gain of phosphorylation at M1 (P = 0.0395);Gain of phosphorylation at M1 (P = 0.0395);Gain of phosphorylation at M1 (P = 0.0395);Gain of phosphorylation at M1 (P = 0.0395);Gain of phosphorylation at M1 (P = 0.0395);Gain of phosphorylation at M1 (P = 0.0395);Gain of phosphorylation at M1 (P = 0.0395);
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at